Loading chat...
NY A03833
Bill
Status
1/30/2025
Primary Sponsor
David Weprin
Click for details
AI Summary
-
Requires all health insurance policies, group/blanket policies, and health service corporation contracts that cover prescription drugs to include coverage for FDA-approved or emergency use authorized antiviral COVID-19 therapeutics
-
Eliminates annual deductibles and coinsurance for covered COVID-19 antiviral treatments, making them available at no out-of-pocket cost to insured individuals
-
Extends the same no-cost coverage requirement to Medicaid recipients through amendments to the social services law
-
Allows insurers to require patients to first use manufacturer or government programs that provide these medications at no cost or reduced cost before utilizing insurance coverage
-
Takes effect January 1 following enactment and applies to all policies issued, renewed, modified, altered, or amended on or after that date
Legislative Description
Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.
Last Action
referred to insurance
1/7/2026